Journal of Drug Targeting

Papers
(The H4-Index of Journal of Drug Targeting is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Methotrexate-Loaded solid lipid nanoparticles enhance the viability of cutaneous flaps: potential for surgical wound healing48
Synergistic cancer treatment using porphyrin-based metal-organic Frameworks for photodynamic and photothermal therapy47
Artificial intelligence-based molecular property prediction of photosensitising effects of drugs43
Nano-based drug delivery systems in hepatocellular carcinoma42
Edoxaban enfolded beta-1,4-poly- d -glucosamine nanoparticles for targeting eponym Stuart–Prower factor for treatment of venous thrombosis40
Resveratrol in ulcerative colitis: therapeutic mechanisms, animal model evidence and novel approaches39
Self-nanoemulsifying drug delivery system (SNEDDS) as nano-carrier framework for permeability modulating approaches of BCS class III drug39
RETRACTED ARTICLE: Melanin-based biomimic photothermal nanoparticles for therapeutic application in diabetic nephropathy34
Statement of Retraction: Melanin-based biomimic photothermal nanoparticles for therapeutic application in diabetic nephropathy31
MicroRNA-206 inhibition and activation of the AMPK/Nampt signalling pathway enhance sevoflurane post-conditioning-induced amelioration of myocardial ischaemia/reperfusion injury29
Emerging targeted therapeutic strategies for the treatment of triple-negative breast cancer28
Progress in tumour-targeted drug delivery based on cell-penetrating peptides26
ROS1-positive non-small cell lung cancer (NSCLC): biology, diagnostics, therapeutics and resistance25
Novel pH-responsive alginate-stabilized curcumin–selenium–ZIF-8 nanocomposites for synergistic breast cancer therapy25
Advances in autophagy as a target in the treatment of tumours24
Cancer stem cell biomarkers and related signalling pathways24
State-of-the-art drug delivery system to target the lymphatics23
Lauric acid-based thermosensitive delivery system for the treatment of head and neck squamous cell carcinoma21
Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis21
Research progress of exosomes as drug carriers in cancer and inflammation21
Advancement in transporter-oriented nanoplatforms for cancer therapy20
In vitro studies support clinical trials showing platelet-rich fibrin-mediated local delivery of antibiotics improves outcomes in impacted mandibular third molar surgery20
Delivery of MERS antigen encapsulated in α-GalCer-bearing liposomes elicits stronger antigen-specific immune responses20
0.076664924621582